Oragenics Inc. (OGEN)
OGEN trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4469
-0.16% on the day
Market cap
$2.0M
Nano cap
Revenue · 2023
$38K
No prior year to compare
Net income · 2023
-$20.7M
-54858.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2023.
Profile
| Field | Value |
|---|---|
| Ticker | OGEN on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001174940 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | FL |
Financials · 2023
| Line | Value |
|---|---|
| Revenue | $38K |
| Net income | -$20.7M |
| Operating income | -$20.9M |
| Net margin | -54858.1% |
| Operating margin | -55519.9% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $3.5M |
| Total assets | $5.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 53.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-01-22 |
| Latest annual report | 10-K | 2026-03-16 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-16 |
| Latest proxy | DEFA14A | 2026-05-20 |
Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GNPX | Genprex Inc. | $2.51 | -6.69% | $2.1M |
| SILO | Silo Pharma Inc. | $1.22 | -18.12% | $2.1M |
| PPBT | Purple Biotech Ltd. | $1.36 | -1.45% | $2.2M |
| SPRC | SciSparc Ltd. | $3.94 | -3.43% | $2.3M |
| ELAB | PMGC Holdings Inc. | $2.96 | -2.95% | $2.4M |
| MTNB | Matinas Biopharma Holdings Inc. | $2.50 | -8.76% | $2.4M |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $0.6939 | -5.08% | $1.6M |
| ARTL | Artelo Biosciences Inc. | $2.98 | -4.18% | $1.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier